Display options
Cite
Breitborde NJ, Dawson SC, Woolverton C, et al. A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder. BMC Psychol. 2014;2(1):41doi: 10.1186/s40359-014-0041-4.
Breitborde, N. J., Dawson, S. C., Woolverton, C., Dawley, D., Bell, E. K., Norman, K., Polsinelli, A., Bernstein, B., Mirsky, P., Pletkova, C., Grucci, F., Montoya, C., Nanadiego, B., Sarabi, E., DePalma, M., & Moreno, F. (2014). A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder. BMC psychology, 2(1), 41. https://doi.org/10.1186/s40359-014-0041-4
Breitborde, Nicholas Jk, et al. "A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder." BMC psychology vol. 2,1 (2014): 41. doi: https://doi.org/10.1186/s40359-014-0041-4
Breitborde NJ, Dawson SC, Woolverton C, Dawley D, Bell EK, Norman K, Polsinelli A, Bernstein B, Mirsky P, Pletkova C, Grucci F, Montoya C, Nanadiego B, Sarabi E, DePalma M, Moreno F. A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder. BMC Psychol. 2014 Oct 10;2(1):41. doi: 10.1186/s40359-014-0041-4. eCollection 2014. PMID: 25566387; PMCID: PMC4270034.
Copy Download .nbib Format: NLM
Share it on

BMC Psychol. 2014 Oct 10;2(1):41. doi: 10.1186/s40359-014-0041-4. eCollection 2014.

A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.

BMC psychology

Nicholas Jk Breitborde, Spencer C Dawson, Cindy Woolverton, David Dawley, Emily K Bell, Kaila Norman, Angelina Polsinelli, Beth Bernstein, Pamela Mirsky, Christine Pletkova, Felix Grucci, Carly Montoya, Bernard Nanadiego, Ehsan Sarabi, Michael DePalma, Francisco Moreno

Affiliations

  1. Department of Psychiatry, The University of Arizona, Tucson, AZ USA.
  2. Department of Psychology, The University of Arizona, Tucson, AZ USA.

PMID: 25566387 PMCID: PMC4270034 DOI: 10.1186/s40359-014-0041-4

Abstract

BACKGROUND: Cognitive remediation (CR) has shown significant promise in addressing the cognitive deficits that accompany serious mental illness. However, this intervention does not appear to completely ameliorate the cognitive deficits that accompany these illnesses. D-cycloserine (DCS), an NMDA receptor partial agonist, has been shown to enhance the therapeutic benefits of learning-based psychosocial interventions for psychiatric disorders. Thus, the goal of this study is to examine the utility of combining cognitive remediation and d-cycloserine in the treatment of cognitive deficits among individuals with bipolar disorder.

METHODS/DESIGN: Approximately forty individuals with bipolar disorder will be recruited to participate in this study. Participants will be randomized to one of two study arms: CR + DCS or CR + placebo. The primary outcome for this study is change in cognitive functioning. We will also examine several secondary outcomes, including the rate of change of cognitive functioning, social functioning, and symptomatology.

DISCUSSION: Cognitive deficits are a rate-limiting factor in functional recovery among individuals with bipolar disorder. Unfortunately, treatment options for these deficits are limited. The results of the proposed study may reveal a valuable intervention strategy (i.e., CR with concurrent DCS) to improve cognitive functioning among individuals with bipolar disorder. Ultimately, this treatment strategy may prove useful in addressing the cognitive deficits that are ubiquitous across serious mental illnesses.

TRIAL REGISTRATION: ClinicalTrials.gov NCT01934972.

References

  1. Schizophr Res. 2000 May 5;42(3):241-7 - PubMed
  2. Arch Gen Psychiatry. 2001 Aug;58(8):763-8 - PubMed
  3. Neuropharmacology. 2001 Sep;41(4):517-22 - PubMed
  4. Pharmacotherapy. 2001 Aug;21(8):891-7 - PubMed
  5. CMAJ. 2001 Nov 13;165(10):1339-41 - PubMed
  6. Psychol Methods. 2001 Dec;6(4):330-51 - PubMed
  7. Aust N Z J Psychiatry. 2003 Oct;37(5):586-94 - PubMed
  8. JAMA. 2003 Nov 26;290(20):2693-702 - PubMed
  9. Psychiatr Serv. 2004 Jan;55(1):54-8 - PubMed
  10. Psychiatry Res. 2004 Jan 30;125(1):1-7 - PubMed
  11. Arch Gen Psychiatry. 2004 Sep;61(9):866-76 - PubMed
  12. Arch Gen Psychiatry. 2004 Nov;61(11):1136-44 - PubMed
  13. Am J Psychiatry. 2005 Mar;162(3):441-9 - PubMed
  14. J Nerv Ment Dis. 2005 Sep;193(9):602-8 - PubMed
  15. Schizophr Res. 2006 Oct;87(1-3):261-9 - PubMed
  16. J Clin Psychiatry. 2006;67 Suppl 9:3-8; discussion 36-42 - PubMed
  17. Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):972-80 - PubMed
  18. Schizophr Res. 2007 Jan;89(1-3):308-11 - PubMed
  19. Schizophr Res. 2007 Jan;89(1-3):251-60 - PubMed
  20. Schizophr Bull. 2007 Nov;33(6):1364-72 - PubMed
  21. Biol Psychiatry. 2007 Oct 15;62(8):835-8 - PubMed
  22. Schizophr Res. 2007 Nov;96(1-3):156-61 - PubMed
  23. Bipolar Disord. 2007 Sep;9(6):571-9 - PubMed
  24. Neuropharmacology. 2007 Dec;53(7):854-62 - PubMed
  25. Am J Psychiatry. 2008 Feb;165(2):203-13 - PubMed
  26. Schizophr Bull. 2008 Nov;34(6):1221-30 - PubMed
  27. Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409 - PubMed
  28. Biol Psychiatry. 2008 Jun 15;63(12):1118-26 - PubMed
  29. Annu Rev Psychol. 2009;60:549-76 - PubMed
  30. Schizophr Res. 2008 Oct;105(1-3):156-64 - PubMed
  31. Schizophr Bull. 2010 Sep;36(5):966-76 - PubMed
  32. Drug Discov Today. 2009 Jul;14(13-14):690-7 - PubMed
  33. Behav Brain Res. 2009 Dec 1;204(1):206-11 - PubMed
  34. Bipolar Disord. 2009 Jun;11 Suppl 2:123-37 - PubMed
  35. Psychiatr Serv. 2009 Nov;60(11):1468-76 - PubMed
  36. CNS Neurosci Ther. 2010 Oct;16(5):298-307 - PubMed
  37. Behav Res Methods. 2009 Nov;41(4):1149-60 - PubMed
  38. J Neurosci. 2010 Feb 17;30(7):2741-54 - PubMed
  39. Biol Psychiatry. 2010 Jun 15;67(12):1205-11 - PubMed
  40. Behav Res Ther. 2010 Jul;48(7):675-9 - PubMed
  41. Bipolar Disord. 2010 Jun;12(4):351-63 - PubMed
  42. Pharmacol Biochem Behav. 2011 Aug;99(2):245-53 - PubMed
  43. Pharmacol Biochem Behav. 2011 Aug;99(2):275-84 - PubMed
  44. BMC Psychiatry. 2011 Jan 12;11:9 - PubMed
  45. Schizophr Res. 2011 Apr;127(1-3):257-61 - PubMed
  46. J Psychiatr Res. 2011 Aug;45(8):1042-7 - PubMed
  47. Clin Pract Epidemiol Ment Health. 2011;7:112-6 - PubMed
  48. Bipolar Disord. 2011 Jun;13(4):323-33 - PubMed
  49. Schizophr Bull. 2012 Jan;38(1):125-34 - PubMed
  50. Schizophr Res. 2012 Jan;134(1):54-8 - PubMed
  51. Schizophr Bull. 2012 Jan;38(1):135-43 - PubMed
  52. Schizophr Bull. 2012 Jan;38(1):114-24 - PubMed
  53. Schizophr Bull. 2012 Jan;38(1):104-13 - PubMed
  54. J Clin Psychiatry. 2012 Apr;73(4):533-7 - PubMed
  55. Br J Psychiatry. 1990 Dec;157:853-9 - PubMed
  56. Handb Exp Pharmacol. 2012;(213):81-111 - PubMed
  57. Lancet. 2012 Dec 15;380(9859):2129-43 - PubMed
  58. Schizophr Res. 2013 May;146(1-3):64-8 - PubMed
  59. Am J Psychiatry. 2013 Aug;170(8):852-9 - PubMed
  60. J Clin Exp Neuropsychol. 2013;35(7):759-74 - PubMed
  61. Schizophr Res. 2014 Mar;153(1-3):177-83 - PubMed
  62. Early Interv Psychiatry. 2017 Jun;11(3):244-249 - PubMed
  63. Schizophr Bull. 1987;13(2):261-76 - PubMed
  64. Psychopharmacol Bull. 1986;22(2):343-81 - PubMed
  65. Br J Psychiatry. 1978 Nov;133:429-35 - PubMed
  66. Biol Psychiatry. 1997 Nov 15;42(10):948-55 - PubMed
  67. Psychol Med. 1998 May;28(3):551-8 - PubMed
  68. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8363-8 - PubMed
  69. J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9 - PubMed

Publication Types